Charcot-Marie-Tooth (CMT) is a hereditary disorder of the peripheral nervous system that strikes 1 person in every 2500. Increasing debilitation of the muscles ultimately leads to their disappearance in the lower legs, feet and hands. Now, researchers from VIB (the Flanders Interuniversity Institute for Biotechnology) have discovered a piece of the molecular puzzle of this disease. Two small 'heat shock' proteins turn out to be crucial - faults in the coding genes lead to the disease. Additional research has shown that these proteins play an important role in many other neurodegenerative disorders as well. This research moves us a step closer to the development of new therapies.
CMT, a serious disorder without a cure
CMT, the most common hereditary disorder of the peripheral nervous system, leads to debilitation of the muscles in the lower legs, feet and hands. The clinical picture is extremely variable, but older patients sometimes require a wheelchair. Today, only supportive treatment is available; there are still no effective therapies to retard or stop the progress of the disease. More insight into the molecular processes of this disease is essential for diagnosis and potential treatment. And exploration of the genes involved is a crucial step in this.
VIB research findings
Joy Irobi and her colleagues - under the direction of Vincent Timmerman and Peter De Jonghe of the Department of Molecular Genetics, University of Antwerp - are concentrating on the genetic and biological study of hereditary disorders of the peripheral nervous system. The largest cells in our body, our peripheral neurons can be 1 meter long in bundles of nerve fibers extending from the spinal cord to the feet.
Recently, the researchers in Antwerp have found mutations in the genetic code of two small 'heat shock' proteins (HSPs) in a number of people with CMT. In stress situations, cells produce HSPs that act as 'chaperones', stabilizingPage: 1 2 Related biology news :1
Contact: Ann Van Gysel
VIB, Flanders Interuniversity Institute of Biotechnology
. Closing in on the cellular culprits of schizophrenia2
. Researchers Closing In On Gene For Paralytic Disorder3
. Leader in cancer treatment and prevention research honored4
. International study findings link acne-like rash to effectiveness of new targeted cancer treatment5
. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia6
. New treatment for fibromyalgia7
. The impact of genetic variations on the treatment of early rheumatoid arthritis8
. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions9
. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find10
. Colleagues to recognize research leadership in cancer detection, prevention and treatment11
. New view of leukemia cells identifies best treatment options, Stanford researchers say